Shrem InvIT manager's board approves up to INR 1,046 crore NaBFID term loan
What the filing says
- Board of Shrem Infra Investment Manager, as Investment Manager of Shrem InvIT, approved additional InvIT-level borrowing on October 20, 2026
- Rupee term loan from NaBFID aggregating up to INR 1,046/- crore, to be paid in tranches
- Purpose: acquisition of SPV(s) and refinance of existing debt; meeting ran from 5.10 p.m. to 5:28 p.m.
Why it's rated notable: The Board approved a rupee term loan of INR 1,046/- crore from NaBFID, which is about 17% of the stated market value of ₹6,231 crore and so meets the high threshold for a fundraise of roughly 5% or more of market value, and it funds an SPV acquisition and refinancing.
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Outcome of Board Meeting
Read the filing on NSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other acquisition / merger filings this fortnight
- Sudarshan Europe B.V. discloses substantial acquisition in Heubach Colorants India Ltd
- Sagility Limited acquires Chirok Health to expand provider-focused services
- Dr. Agarwal’s Eye Hospital Ltd approves Scheme of Amalgamation effective Nov 1, 2026
- Dr. Agarwal's Health Care board notes amalgamation scheme effective Nov 1, 2026
- Kwality Pharmaceuticals acquires 4 acres for manufacturing expansion in Amritsar
- EPL Limited receives no-objection letters from BSE and NSE for Scheme of Amalgamation
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.